Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Preferred Shares (2021 - 2025)

Bioregenx's Preferred Shares history spans 5 years, with the latest figure at $4.0 for Q4 2025.

  • Quarterly results put Preferred Shares at $4.0 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $4.0 (changed 0.0% YoY), and the annual figure for FY2025 was $4.0, changed 0.0%.
  • Preferred Shares for Q4 2025 was $4.0 at Bioregenx, roughly flat from $4.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $5000.0 in Q4 2022 to a low of $4.0 in Q4 2023.
  • The 5-year median for Preferred Shares is $4.0 (2023), against an average of $1781.1.
  • The sharpest move saw Preferred Shares grew 2.04% in 2022, then crashed 99.92% in 2023.
  • Year by year, Preferred Shares stood at $4900.0 in 2021, then grew by 2.04% to $5000.0 in 2022, then tumbled by 99.92% to $4.0 in 2023, then changed by 0.0% to $4.0 in 2024, then changed by 0.0% to $4.0 in 2025.
  • According to Business Quant data, Preferred Shares over the past three periods came in at $4.0, $4.0, and $4.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.